2-1. |
|
Global partnership for open innovation
Hunwoo Shin, SVP at MSD
|
|
2-2. |
|
Challenge for the first local antibody-drug for cancer therapy
Yoo Jin San, CEO of Pharmabcine
|
|
2-3. |
|
Human micro-biome technology platform
Prof. Ko, Gwang Pyo, CEO of Kobiolab
|
|
2-4. |
|
1011 diversity, cDNA library and identifying candidate substance
Park, Young Woo, CEO of Y biologics
|
|
2-5. |
|
Stem cell treatment development status and joint research
Rhee, Byung Gun, CEO of SCM Lifescience
|
|
2-6. |
|
Clinical development trend by using nano bio-technology
Kyung Hae Lee, Director of Bio-graphene
|
|